¿ì²¥ÊÓƵ

The Swiss Competition Commission Are Coming! Novartis Dawn Raid shows clash between patent exclusivity and anti-competitive behaviours

Learning About the Business of Healthcare and Innovation: My Internship Experience at AstraZeneca Canada

United States Bill S. 4734: Should Diagnostic Tests be Eligible for Patent Protection

The Role of Patents: A Competition Sword or Shield

Gilead and ViiV Healthcare Settle Global Patent Dispute for Over $1B USD

The Final Countdown? The Upcoming Changes to the Patented Medicines Regulations

The Competition Bureau And Health Canada Issue Joint Notice On Continued Collaboration In Pharmaceutical Sector

Insulin Biohackers: Shaking Up a Billion-Dollar Industry

TRIPS: A Barrier to Covid-19 Vaccine Access?

What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work

This past November, Professor Ronald E. Pearlman from ¿ì²¥ÊÓƵ’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR genome editing system. Central to the talk was the evolving nature of genome editing technology and the ethical concerns that come with its growing breadth of […]